Election 2014
SENSEX NIFTY

Pharma

Apr 24, 2014 at 18:02 | Source: PTI
"2013-14 has seen slowdown in growth because of the US raising concerns and due to increase in global competition," said PV Appaji, Executive Director, Pharmexcil.
Apr 23, 2014 at 17:36 | Source: CNBC-TV18
Dilip Bhat, Joint MD at Prabhudas Lilladher prefers Larsen and Toubro from the capital goods space, Axis Bank from the banking space and Bajaj Auto from the auto space.
Apr 23, 2014 at 15:21 | Source: CNBC-TV18
According to Ashish Chaturmohta of Fortune Equity Brokers, one may go long in Aurobindo Pharma with a target of Rs 595-600.
Apr 23, 2014 at 12:27 | Source: CNBC-TV18
Shahina Mukadam of Varun Capital recommends buying Titan Company with a target of Rs 270 and Tata Global Beverage with a target of Rs 160.
Apr 23, 2014 at 11:33 | Source: Moneycontrol.com
ICICIdirect.com is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 676, in its research report dated April 22, 2014.
Apr 23, 2014 at 11:00 | Source: Moneycontrol.com
HDFC, NTPC, Hindalco, Tata Motors and Sesa Sterlite are among the laggards. Sun Pharma, BHEL, Axis Bank, L&T and ONGC are gainers in the Sensex.
Apr 23, 2014 at 10:16 | Source: Moneycontrol.com
According to Ajay Jain, CEO of astromoneyguru.com, pharma, banking, metal and coffee sectors may show positive move in Indian stock market.
Apr 23, 2014 at 10:00 | Source: Moneycontrol.com
Engineering and construction major Larsen & Toubro and state-run power equipment maker BHEL climbed 1.7 percent each. IT majors TCS and Infosys advanced 0.5-1 percent.
Apr 23, 2014 at 08:47 | Source: CNBC-TV18
Vishal Malkan, malkansview.com advises buying Divis Labs for a target price of Rs 1390 and Exide Industries for a target price of Rs 139.
Apr 22, 2014 at 14:04 | Source: CNBC-TV18
Dipan Mehta, member at BSE & NSE is positive on pharma sector.
Messages on Pharma »

vaibhavthub
e

Silver Member

2 Followers

Just Posted  

Yes why not only buy selected stock like sun pharma,sbi and larson turbo buy 1o stock each daily or option

11.10 PM Apr 24th

vaibhavthub
e

Silver Member

2 Followers

Just Posted  

Yes why not only buy selected stock like sun pharma,sbi and larson turbo buy 1o stock each daily or option

11.07 PM Apr 24th

DrAcS

Gold Member

2 Followers

Adani Enterpris  

coming from future? ;) IMO all the future references are speculations , IT might not show same growth due to INR psb will have npa issues consumption slowing auto having declining sales pharma exports have slowed down

11.06 PM Apr 24th

Reach4Stars

Silver Member

20 Followers

Natco Pharma  

in 6 Months (assuming 50% price drop and 40% share - conservative estimate). With generic Copaxone and Tamiflu - this will give an ORBITAL SHIFT to financials of Natco Pharma. FY 2015 annual profit of Rs 750 Cr - 900 Cr is definitely on the cards now. Remember the annual profit of Natco at present

10.38 PM Apr 24th

indvest2013

Silver Member

3 Followers

Alembic Pharma  

Shmarketgenius - your pharma sector knowledge is really commendable and you give good insights. Keep up the good work.

10.29 PM Apr 24th

nakul

Platinum Member

468 Followers

Bafna Pharma  

outgo is big.Thats need to be taken care of. They have International standard facilities and the trend is now,MNC giving open offer for such Cos which have already such Internationally approved facilities. Bafna Pharma is a Longterm play.It can shoot up in next 3 or 6 months as well.Depends upon how

10.20 PM Apr 24th

gautum

Silver Member

1 Followers

Dishman Pharma  

when will dishman pharma become diishum dishum pharma

8.01 PM Apr 24th

ampandya84

New Member

1 Followers

Motherson Sumi  

Motherson Sumi Target 360-380 SL 246 RESIS. - 264.85 (MAX ONE MONTH) Suprajit Eng Target 82 - 88 SL 67 RESIS. 75 (MAX ONE MONTH) Alembic Pharma Target 360-380-400 SL 278 / 268 TRADING ABOVE RESIS. AND WILL FLY NOW (MAX ONE MONTH) ALEMBIC LTD Target 28 SL 17 RESIS. 20.50 (TWO MONTHS) AMARA RAJA BATT

7.02 PM Apr 24th

ampandya84

New Member

1 Followers

Motherson Sumi  

Apart from Motherson Sumi one can eye on Alembic Pharma as suggested earlier at 222 Rs to buy for target of 1300 for one year and short term target 360 now its started journey towards 360 levels and one can go long as earlier suggest with stop loss for current level buy at around 278 for target

6.56 PM Apr 24th

Natesan

Silver Member

2 Followers

Glenmark  

Glenmark Pharma has lost its three-year patent battle over Abbott‘s hypertension drug, Tarka, and will have to pay $25 million for patent infringement. Glenmark had launched the generic version of the Tar-ka in the US market with six-month exclusivity in 2010.

6.52 PM Apr 24th

News across the web »
Apr 24, 2014 at 19:57 | Source: Business Today
Apr 24, 2014 at 18:46 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.